Arrowstreet Capital Limited Partnership acquired a new stake in Organigram Holdings Inc. (NASDAQ:OGI - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 721,330 shares of the company's stock, valued at approximately $1,153,000. Arrowstreet Capital Limited Partnership owned 0.57% of Organigram at the end of the most recent quarter.
Other institutional investors also recently bought and sold shares of the company. Toronto Dominion Bank lifted its stake in Organigram by 803.7% during the third quarter. Toronto Dominion Bank now owns 16,727 shares of the company's stock worth $30,000 after purchasing an additional 14,876 shares in the last quarter. Clear Harbor Asset Management LLC lifted its stake in Organigram by 37.4% during the 4th quarter. Clear Harbor Asset Management LLC now owns 45,000 shares of the company's stock worth $72,000 after acquiring an additional 12,250 shares in the last quarter. Finally, Tidal Investments LLC boosted its holdings in Organigram by 8.3% during the 3rd quarter. Tidal Investments LLC now owns 1,948,188 shares of the company's stock valued at $3,526,000 after acquiring an additional 149,171 shares during the period. 34.63% of the stock is owned by hedge funds and other institutional investors.
Organigram Price Performance
Shares of NASDAQ OGI traded up $0.01 during midday trading on Thursday, hitting $1.05. The company's stock had a trading volume of 161,427 shares, compared to its average volume of 767,921. The firm has a market capitalization of $131.94 million, a price-to-earnings ratio of -2.75 and a beta of 1.10. The business's fifty day simple moving average is $1.11 and its two-hundred day simple moving average is $1.44. Organigram Holdings Inc. has a 1 year low of $0.85 and a 1 year high of $2.17.
Organigram (NASDAQ:OGI - Get Free Report) last issued its quarterly earnings results on Tuesday, February 11th. The company reported ($0.05) EPS for the quarter, missing the consensus estimate of ($0.03) by ($0.02). Organigram had a negative net margin of 31.69% and a negative return on equity of 8.59%. Analysts anticipate that Organigram Holdings Inc. will post -0.19 EPS for the current fiscal year.
About Organigram
(
Free Report)
Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.
Further Reading
Before you consider Organigram, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Organigram wasn't on the list.
While Organigram currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
